Rafoxanide
Names | |
---|---|
IUPAC name
N-[3-Chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3,5-diiodobenzamide | |
Other names
Rafoxanid, raphoxanide | |
Identifiers | |
22662-39-1 | |
3D model (Jmol) | Interactive image |
ChEMBL | ChEMBL287542 |
ChemSpider | 29191 |
ECHA InfoCard | 100.041.029 |
EC Number | 245-148-9 |
KEGG | D05693 |
MeSH | D011888 |
PubChem | 31475 |
UNII | 22F4FLA7DH |
| |
| |
Properties | |
C19H11Cl2I2NO3 | |
Molar mass | 626.01 g/mol |
Appearance | Slight yellowish-brown injectable solution and white oral solution |
In oily solutes | |
Pharmacology | |
QP52AG05 (WHO) | |
Hazards | |
Main hazards | Has low safety index (6 times as normal dose) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is ?) | |
Infobox references | |
Rafoxanide is a salicylanilide used as an anthelmintic.
This article is issued from Wikipedia - version of the 10/3/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.